Artemis Bioservices is an expert in virology service. We provide high level preclinical and clinical services in the area of virology and immune-virology. The team has years of experience in evaluating and understanding vaccine and antiviral efficacy using in vitro and in vivo models. Artemis Bioservices has a lot of experience with the design, development and validation of assays necessary in all phases of research. Artemis Bioservices has ample experience with Bio-Safety Level 3 viruses, in particular arbo- and zoonotic viruses.
Artemis Bioservices offers a one-stop shop model, because it has strong partnerships with organizations that play a critical role in the preclinical and clinical phases of the evaluation of vaccines, antivirals or biosimilars. Our collaborative model is critical to the success of our one-stop shop model. A fully collaborative contract is founded upon co-creation. Together we look at the project’s scope of work, transparency, and joint governance. These elements translate into four major practices: partners working together during a defined preplanning period, a single contract among key partners, a no-fault clause, and a clear management structure.
Artemis Bioservices developed a unique algorithm that allows an integrated analysis of immunogenicity and efficacy data. With this Immunogenicity package we create our own data, while adding to our client’s data.
Artemis Bioservices provides clients with customized services and advice targeted to their needs. To ensure our clients are satisfied with our services we are responsive and flexible.